Plasma endothelin-1 levels in Takayasu's arteritis

被引:20
作者
Akazawa, H [1 ]
Ikeda, U [1 ]
Kuroda, T [1 ]
Shimada, K [1 ]
机构
[1] JICHI MED SCH,DEPT CARDIOL,MINAMI KAWACHI,TOCHIGI 32904,JAPAN
关键词
endothelin-1; Takayasu's arteritis; thrombomodulin;
D O I
10.1159/000177110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We measured plasma endothelin-1 (ET-1) levels in patients with Takayasu's arteritis to investigate its relationship with the disease activity. We also measured plasma thrombomodulin (TM) levels as a marker of endothelial injury. A significant positive correlation was evident between plasma ET-1 levels and erythrocyte sedimentation rates (ESRs) in patients with Takayasu's arteritis (r = 0.53, p < 0.005). In contrast, plasma levels of TM did not show a significant correlation with ESRs (r = -0.13). ET-1, secreted in this way during the active stages of Takayasu's arteritis, may cause constriction and proliferation of vascular smooth muscle cells and, as a result, progression of luminal narrowing of the affected vessels in this disorder.
引用
收藏
页码:303 / 305
页数:3
相关论文
共 10 条
[1]  
AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129
[2]   COMPARISON OF 3 DOPPLER ULTRASOUND METHODS IN THE PREDICTION OF PULMONARY-ARTERY PRESSURE [J].
CHAN, KL ;
CURRIE, PJ ;
SEWARD, JB ;
HAGLER, DJ ;
MAIR, DD ;
TAJIK, AJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (03) :549-554
[3]  
ESMON NL, 1982, J BIOL CHEM, V257, P859
[4]   PULMONARY-ARTERY INVOLVEMENT IN TAKAYASUS ARTERITIS [J].
LUPIH, E ;
SANCHEZT, G ;
HORWITZ, S ;
GUTIERREZ, E .
CHEST, 1975, 67 (01) :69-74
[5]   TAKAYASUS ARTERITIS - CLINICAL-STUDY OF 107 CASES [J].
LUPIHERRERA, E ;
SANCHEZTORRES, G ;
MARCUSHAMER, J ;
MISPIRETA, J ;
HORWITZ, S ;
ESPINOVELA, J .
AMERICAN HEART JOURNAL, 1977, 93 (01) :94-103
[6]   INCREASED PLASMA ENDOTHELIN-1 IN PULMONARY-HYPERTENSION - MARKER OR MEDIATOR OF DISEASE [J].
STEWART, DJ ;
LEVY, RD ;
CERNACEK, P ;
LANGLEBEN, D .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (06) :464-469
[7]   PLASMA VONWILLEBRAND-FACTOR AND THROMBOMODULIN AS MARKERS OF VASCULAR DISORDERS IN PATIENTS UNDERGOING REGULAR HEMODIALYSIS THERAPY [J].
TOMURA, S ;
NAKAMURA, Y ;
DEGUCHI, F ;
CHIDA, Y ;
OHNO, Y ;
KODAMA, S ;
HAYASHI, T ;
SUZUKI, K ;
MARUMO, F .
THROMBOSIS RESEARCH, 1990, 58 (04) :413-419
[8]   PLASMA THROMBOMODULIN AS A MARKER OF VASCULAR DISORDERS IN THROMBOTIC THROMBOCYTOPENIC PURPURA AND DISSEMINATED INTRAVASCULAR COAGULATION [J].
WADA, H ;
OHIWA, M ;
KANEKO, T ;
TAMAKI, S ;
TANIGAWA, M ;
SHIRAKAWA, S ;
KOYAMA, M ;
HAYASHI, T ;
SUZUKI, K .
AMERICAN JOURNAL OF HEMATOLOGY, 1992, 39 (01) :20-24
[9]   ENDOTHELIN PRODUCTION IN PULMONARY CIRCULATION OF PATIENTS WITH MITRAL-STENOSIS [J].
YAMAMOTO, K ;
IKEDA, U ;
MITO, H ;
FUJIKAWA, H ;
SEKIGUCHI, H ;
SHIMADA, K .
CIRCULATION, 1994, 89 (05) :2093-2098
[10]   A NOVEL POTENT VASOCONSTRICTOR PEPTIDE PRODUCED BY VASCULAR ENDOTHELIAL-CELLS [J].
YANAGISAWA, M ;
KURIHARA, H ;
KIMURA, S ;
TOMOBE, Y ;
KOBAYASHI, M ;
MITSUI, Y ;
YAZAKI, Y ;
GOTO, K ;
MASAKI, T .
NATURE, 1988, 332 (6163) :411-415